HCM
ABBV icon

Highfields Capital Management’s AbbVie ABBV Stock Holding History

Highfields Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,948,258
Closed -$372M – 68
2016
Q4 		$372M Sell
5,948,258
-2,014,581
-25% -$123M 3.09% 9
2016
Q3 		$502M Hold
7,962,839
– – 4.71% 6
2016
Q2 		$493M Hold
7,962,839
– – 4.3% 6
2016
Q1 		$455M Buy
7,962,839
+2,054,339
+35% +$115M 4.25% 7
2015
Q4 		$350M Buy
5,908,500
+2,583,500
+78% +$149M 3.02% 8
2015
Q3 		$181M Buy
+3,325,000
New +$216M 1.6% 20

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Highfields Capital Management's ABBV Position: Q1 2017 in Review

Highfields Capital Management sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 5,948,258 shares — an estimated $372M sold.

Highfields Capital Management first reported a position in ABBV in Q3 2015 and held it in 6 quarters. The position peaked at $502M in Q3 2016. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Highfields Capital Management reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Highfields Capital Management sold 5,948,258 AbbVie shares in Q1 2017, an estimated $372M.
  • Highfields Capital Management first reported a position in AbbVie in Q3 2015 and held it in 6 quarters.
  • Highfields Capital Management's AbbVie position peaked at $502M in Q3 2016.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Highfields Capital Management's 13F filing for Q1 2017, filed 15 May 2017.